Details

Notice to Stakeholders - Updates to drug establishment licence applications and good manufacturing practice evidence requirements for active pharmaceutical ingredients - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 3, 2026 · edition #6
Timestamp: 2026-03-03T05:37:48.931Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html
Replay URL: https://replay.healtharchive.ca/job-6/20260303053748/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/notice-stakeholders-updates-drug-establishment-licence-applications-good-manufacturing-practice-evidence-requirements-active-pharmaceutical.html#ha_snapshot=617322
ID: 617322
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots